Advancis Pharmacautical enters marketing agreement with Innovex

Advancis Pharmaceutical Corporation has entered into a two-year sales and marketing agreement with Innovex for 75 sales reps to promote Advancis' recently approved cephalosporin antibiotic Keflex (cephalexin). Promotion of Keflex was scheduled to begin in mid-July.
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical